Sunday 7 February 2016
 
»
Tag
 
»
Roche

Seven $1bn-plus drugs to hit market in 2016

Drug companies are likely to launch seven "blockbuster" drugs in 2016, each with $1 billion-plus annual sales potential, led by new treatments for liver disease and HIV, according to a Thomson Reuters analysis. The asses

More…

Drugmaker Shire to buy Baxalta for $32bn

Drugmaker Shire clinched its six-month pursuit of Baxalta International on Monday with an agreed $32 billion cash and stock offer, catapulting it to a leading position in treating rare diseases. The London-listed group, which firs

More…

Drugmaker Shire to buy Baxalta for $32bn

Drugmaker Shire clinched its six-month pursuit of Baxalta International on Monday with an agreed $32 billion cash and stock offer, catapulting it to a leading position in treating rare diseases. The London-listed group, which firs

More…

Roche Media Academy wins healthcare and services award

A Roche Media Academy initiative won the Silver Award in Healthcare and Services category at the Middle East Public Relations Association Awards (Mepra) 2015.   Launched by Roche UAE last year, the Roche Media Ac

More…

Experts raise concern on lack of cancer awareness

Roche Media Academy, a leader in research-focused healthcare, brought together leading medical experts and journalists to organise an informative session themed 'Women's Cancer in UAE: Cervical and Ovarian Cancer' in Dubai, UAE, re

More…

Roche evaluates investigational medicine in PPMS patients

Roche, a leader in research focused healthcare, revealed the results from a pivotal Phase III study that evaluated an investigational medicine in people with primary progressive multiple sclerosis (PPMS).   The s

More…

Roche surges ahead in race for MS treatment

Switzerland's Roche has moved into pole position in the race to launch the world's first treatment for progressive multiple sclerosis but smaller players are working hard on rival approaches. While there are a number of tr

More…

Swiss drugmaker Roche buys France's Trophos

Swiss drugmaker Roche said on Friday it had agreed to buy privately-held Trophos to gain access to an experimental drug to treat a debilitating genetic neuromuscular disease. The acquisition is the latest in a spate of deals by Ro

More…

Roche wins top pharma award

Roche, a Swiss global healthcare company, has been recognised by the Dow Jones Sustainability Indices (DJSI) as the group leader in sustainability within the pharmaceuticals, biotechnology and life sciences industry for the sixth consecutive yea

More…

Roche plans to steer clear of big acquisitions

Roche plans to steer clear of the wave of big takeovers sweeping through the healthcare industry and focus instead on small acquisitions and partnerships, the Swiss drugmaker's chief executive said in an inte

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads